• Hoechst 33342 for Fibroblast Senescence Assays

  2026-10-02

  Explore how Hoechst 33342 nuclear stain strengthens live and fixed fibroblast senescence assays. This article explains how nuclear readouts complement mitochondrial quality measurements without being mistaken for direct evidence of mitophagy.

• AO/PI Staining Solution for Better Cell Viability Data

  2026-10-01

  Discover how AO/PI Staining Solution converts membrane integrity into a practical live/dead cell readout for diabetic nephropathy research. This guide connects dual-fluorescence counting with the mechanistic findings of the phillygenin study while defining appropriate assay limits and controls.

• Lactobacillus acidophilus, UDCA, and Ulcerative Colitis

  2026-10-01

  Deng et al. show that Lactobacillus acidophilus may alleviate ulcerative colitis through a microbiota-dependent increase in ursodeoxycholic acid, rather than through probiotic administration alone. Their in vivo, metabolomics, and cell-based experiments connect UDCA with enhanced Treg differentiation, reduced M1 macrophage polarization, and regulation of the RapGap/PI3K-AKT/NF-κB pathway.

• DBcAMP Sodium Salt in Neurobiology

  2026-09-30

  Explore how Dibutyryl-cAMP, sodium salt can function as a controlled cAMP perturbation tool in neurobiology, from PKA assays to tau-focused models. This evidence-aware guide connects DBcAMP sodium salt with model selection, assay controls, and the Alzheimer’s disease findings of a 2024 brain-slice study.

• DNase I (GMP-grade) in RNA-CRISPR Workflows

  2026-09-30

  DNase I (GMP-grade) can improve the interpretability of RNA-targeting CRISPR experiments by controlling DNA carryover during preparation and quality assessment. This article connects nuclease hygiene with the cytosolic crRNA design principles reported for Cas13 systems.

• Ferrostatin-1: A Causal Probe of Ferroptosis

  2026-09-29

  Ferrostatin-1 (Fer-1) is more than a ferroptosis inhibitor: it can function as a causal probe for connecting lipid peroxidation to the HDAC3–NRF2–GPX4 axis. This guide translates recent colorectal cancer findings into rigorous assay-design and interpretation strategies.

• DiscoveryProbe Natural Product Library Plus for HTS

  2026-09-29

  The DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library for HTS and HCS. Its pre-dissolved 10 mM DMSO format supports automated screening, while published CpAdhE research provides a target-to-cell framework for antiparasitic hit validation.

• Pedalitin, FOXO Signaling, and NAFLD Cell Models

  2026-09-28

  The reference study integrates network pharmacology, molecular docking, and LO2 hepatocyte experiments to investigate how pedalitin may influence lipid accumulation and inflammatory signaling in non-alcoholic fatty liver disease. Its findings support a hypothesis involving fatty acid metabolism and the FOXO pathway, while also illustrating why computational predictions require targeted cellular and biochemical validation.

• SpCas9 mRNA: From Molecular Design to Editing Strategy

  2026-09-28

  A translational framework for connecting SpCas9 mRNA chemistry to delivery, DNA repair, and reproducible genome editing—using mouse zygote electroporation as a case study.

• AO/PI Staining Solution for Kidney Injury Studies

  2026-09-27

  AO/PI Staining Solution separates membrane-intact from membrane-compromised cells in fluorescence-based counts, helping researchers interpret viability changes in high-glucose podocyte models. Use it as a rapid live/dead readout alongside—not instead of—the pathway and apoptosis assays used to study phillygenin in diabetic nephropathy.

• Lowe Syndrome: From OCRL Rescue to Readthrough

  2026-09-26

  A translational perspective on OCRL gene augmentation and CRISPR correction in patient-derived trabecular meshwork models, and on how PTC124 (Ataluren) could be evaluated as a distinct, mutation-dependent research strategy.

• PTC124 (Ataluren) in OCRL Rescue Assays

  2026-09-25

  Use PTC124 (Ataluren) as an exploratory, mutation-specific readthrough arm alongside OCRL gene augmentation and CRISPR correction—not as a substitute for either strategy. This workflow shows how to screen eligible nonsense variants in patient-derived trabecular meshwork cells while separating molecular rescue from functional recovery.

• PD 0332991 (Palbociclib HCl): Evidence & Use

  2026-09-25

  PD 0332991, also called Palbociclib HCl, is a selective CDK4/6 inhibitor used to study Rb-dependent cell-cycle control. Product-dossier benchmarks report nanomolar CDK4/6 inhibition, G1-phase effects in vitro, and oral tumor-growth suppression in mouse xenograft models; these findings are preclinical, not evidence of clinical efficacy for this research reagent.

• PTC124 (Ataluren) in Lowe Syndrome Ocular Models

  2026-09-24

  PTC124 (Ataluren) offers a mutation-dependent readthrough strategy that is mechanistically distinct from OCRL gene augmentation and CRISPR correction. This article explains how to evaluate it as a research hypothesis in Lowe syndrome trabecular meshwork models—and why the available study does not establish ataluren efficacy.

• From H3K9me3 to Rice Blast: A qPCR Strategy

  2026-09-24

  A recent study links the Cullin4 protein MoCul4 with MoKmt1-dependent H3K9 trimethylation and key traits in the rice blast fungus. This article considers what the findings establish, where targeted RT-qPCR can strengthen follow-up studies, and how to position gene-expression measurements within a broader translational evidence package.

528 records 1/36 page Next 12345 下5页 Last page